Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder A Randomized, Double-Blind, Placebo-Controlled, 8-Week Study of Vilazodone, a Serotonergic Agent for the Treatment of Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Clinical Evidence and Potential Neurobiological Underpinnings of Unresolved Symptoms of Depression PDF $40.00
$40.00
× Placeholder Outcomes of Late-Life Anxiety Disorders During 32 Weeks of Citalopram Treatment PDF $40.00
$40.00
× Placeholder Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine PDF $40.00
$40.00
× Placeholder The Implication of Combat Stress and PTSD Trajectories in Metabolic Syndrome and Elevated C-Reactive Protein Levels: A Longitudinal Study PDF $40.00
$40.00
× Placeholder Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial PDF $40.00
$40.00
× Placeholder Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $280.00
Total $280.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe